Intratumoral microbial heterogeneity affected tumor immune microenvironment and determined clinical outcome of HBV-related HCC

21Citations
Citations of this article
18Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Background and Aims: The intratumoral microbiome has been reported to regulate the development and progression of cancers. We aimed to characterize intratumoral microbial heterogeneity (IMH) and establish microbiome-based molecular subtyping of HBV-related HCC to elucidate the correlation between IMH and HCC tumorigenesis. Approach and Results: A case-control study was designed to investigate microbial landscape and characteristic microbial signatures of HBV-related HCC tissues adopting metagenomics next-generation sequencing. Microbiome-based molecular subtyping of HCC tissues was established by nonmetric multidimensional scaling. The tumor immune microenvironment of 2 molecular subtypes was characterized by EPIC and CIBERSORT based on RNA-seq and verified by immunohistochemistry. The gene set variation analysis was adopted to explore the crosstalk between the immune and metabolism microenvironment. A prognosis-related gene risk signature between 2 subtypes was constructed by the weighted gene coexpression network analysis and the Cox regression analysis and then verified by the Kaplan-Meier survival curve. IMH demonstrated in HBV-related HCC tissues was comparably lower than that in chronic hepatitis tissues. Two microbiome-based HCC molecular subtypes, defined as bacteria-and virus-dominant subtypes, were established and significantly correlated with discrepant clinical-pathologic features. Higher infiltration of M2 macrophage was detected in the bacteria-dominant subtype with to the virus-dominant subtype, accompanied by multiple upregulated metabolism pathways. Furthermore, a 3-gene risk signature containing CSAG4, PIP4P2, and TOMM5 was filtered out, which could predict the clinical prognosis of HCC patients accurately using the Cancer Genome Atlas data. Conclusions: Microbiome-based molecular subtyping demonstrated IMH of HBV-related HCC was correlated with a disparity in clinical-pathologic features and tumor microenvironment (TME), which might be proposed as a biomarker for prognosis prediction of HCC.

References Powered by Scopus

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

66881Citations
N/AReaders
Get full text

Hepatocellular carcinoma

4344Citations
N/AReaders
Get full text

Hepatocellular carcinoma

3346Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Broadening oncological boundaries: the intratumoral microbiota

13Citations
N/AReaders
Get full text

The microbiome and rise of early-onset cancers: knowledge gaps and research opportunities

10Citations
N/AReaders
Get full text

Understanding gut dysbiosis for hepatocellular carcinoma diagnosis and treatment

8Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Li, S., Xia, H., Wang, Z., Zhang, X., Song, T., Li, J., … Lu, W. (2023). Intratumoral microbial heterogeneity affected tumor immune microenvironment and determined clinical outcome of HBV-related HCC. Hepatology, 78(4), 1079–1091. https://doi.org/10.1097/HEP.0000000000000427

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 7

70%

Professor / Associate Prof. 1

10%

Lecturer / Post doc 1

10%

Researcher 1

10%

Readers' Discipline

Tooltip

Medicine and Dentistry 5

42%

Biochemistry, Genetics and Molecular Bi... 3

25%

Immunology and Microbiology 3

25%

Pharmacology, Toxicology and Pharmaceut... 1

8%

Article Metrics

Tooltip
Mentions
News Mentions: 1

Save time finding and organizing research with Mendeley

Sign up for free